Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

141 ARTÍCULOS , VIENDO DEL 16 AL 30

Mapping out biomarkers for Alzheimer disease

Breteler MM.

JAMA. 2011 Jan 19;305(3):304-5. doi: 10.1001/jama.2010.2017.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1

Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC.

Alzheimers Dement. 2011 Jan;7(1):15-34. doi: 10.1016/j.jalz.2010.11.005.

An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease

Mizukami K, Ishikawa M, Akatsu H, Abrahamson EE, Ikonomovic MD, Asada T.

Neuropathology. 2011 Oct;31(5):503-9. doi: 10.1111/j.1440-1789.2010.01193.x. Epub 2011 Jan 27.

Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease

Rahmadi A, Steiner N, Münch G.

Clin Chem Lab Med. 2011 Mar;49(3):385-91. doi: 10.1515/CCLM.2011.079. Epub 2011 Jan 31.

Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study

Acosta-Baena N, Sepulveda-Falla D, Lopera-Gómez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, Saldarriaga A, Lopera F.

Lancet Neurol. 2011 Mar;10(3):213-20. doi: 10.1016/S1474-4422(10)70323-9. Epub 2011 Feb 4.

Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease

Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Björkhem I, Cedazo-Mínguez A.

J Alzheimers Dis. 2011;24(4):669-79. doi: 10.3233/JAD-2011-101512.

Biomarkers in Alzheimer's disease

Demarin V, Zavoreo I, Kes VB, Simundić AM.

Clin Chem Lab Med. 2011 May;49(5):773-8. doi: 10.1515/CCLM.2011.139. Epub 2011 Feb 9.

Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid

Schipke CG, Prokop S, Heppner FL, Heuser I, Peters O.

Dement Geriatr Cogn Disord. 2011;31(2):139-45. doi: 10.1159/000322588. Epub 2011 Feb 8.

Epidemiology of Alzheimer disease

Reitz C, Brayne C, Mayeux R.

Nat Rev Neurol. 2011 Mar;7(3):137-52. doi: 10.1038/nrneurol.2011.2. Epub 2011 Feb 8.

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Acta Neuropathol. 2011 May;121(5):597-609. doi: 10.1007/s00401-011-0808-0. Epub 2011 Feb 11.

Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection

Arisi I, D'Onofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G, Felici G, Weitschek E, Bertolazzi P, Cattaneo A.

J Alzheimers Dis. 2011;24(4):721-38. doi: 10.3233/JAD-2011-101881.

Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus

Tiribuzi R, Orlacchio A, Crispoltoni L, Maiotti M, Zampolini M, De Angeliz M, Mecocci P, Cecchetti R, Bernardi G, Datti A, Martino S, Orlacchio A.

J Alzheimers Dis. 2011;24(4):785-97. doi: 10.3233/JAD-2011-100525.

Human serum transthyretin levels correlate inversely with Alzheimer's disease

Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, Na DL, Kim M, Kim H, Ha HJ, Kim YH, Huh N, Jung MW, Mook-Jung I.

J Alzheimers Dis. 2011;25(1):77-84. doi: 10.3233/JAD-2011-102145.

Longitudinal MR imaging in Alzheimer disease: a study anyone can join

Bizzi A.

Radiology. 2011 Mar;258(3):657-9. doi: 10.1148/radiol.10102254.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias